-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, Ikc/N9xqHh1tMsKvV0fyRjYPo+HbhvTM06ICThk5qE31YURzFSVkEtq7fZba2iW8 5GP0y5RuDXFzZW01K7wDHw== 0001238916-03-000004.txt : 20030714 0001238916-03-000004.hdr.sgml : 20030714 20030714172158 ACCESSION NUMBER: 0001238916-03-000004 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20030714 FILED AS OF DATE: 20030714 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: BUECHLER KENNETH F CENTRAL INDEX KEY: 0001238916 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-21873 FILM NUMBER: 03785882 BUSINESS ADDRESS: STREET 1: C/O BIOSITE INC STREET 2: 11030 ROSELLE STREET CITY: SAN DIEGO STATE: CA ZIP: 92121 BUSINESS PHONE: 8584554808 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: BIOSITE INC CENTRAL INDEX KEY: 0000834306 STANDARD INDUSTRIAL CLASSIFICATION: IN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES [2835] IRS NUMBER: 330288606 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 11030 ROSELLE ST CITY: SAN DIEGO STATE: CA ZIP: 92121 BUSINESS PHONE: 6194554808 MAIL ADDRESS: STREET 1: 11030 ROSELLE ST CITY: SAN DIEGO STATE: CA ZIP: 92121 FORMER COMPANY: FORMER CONFORMED NAME: BIOSITE DIAGNOSTICS INC DATE OF NAME CHANGE: 19960710 4 1 edgardoc.xml PRIMARY DOCUMENT X0101 4 2003-07-14 0 0000834306 BIOSITE INC BSTE 0001238916 BUECHLER KENNETH F 1 1 0 0 Officer Common Stock 2003-07-14 4 M 0 5000 10 A 5000 D Common Stock 2003-07-14 4 S 0 5000 56.9 D 0 D Non-Qualified Stock Option (right to buy) 10 2003-07-14 4 M 0 5000 0 D 1999-06-09 2009-06-09 Common Stock 5000 26138 D This information should appear in Column 5 of the Form 4. End of period holdings does not include 288,360 shares held indirectly by family trust of which 743 shares were purchased in connection with the Company's ESPP plan on 6/30/03. The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on June 11, 2003. Option vests daily over a four-year period commencing on the date of grant, except that no options are exercisable for the first six months after the date of grant. By: Robyn Shutak For: Kenneth F. Buechler 2003-07-14 -----END PRIVACY-ENHANCED MESSAGE-----